Entrada Therapeutics Growth Metrics (2022-2025) | TRDA

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 50.16%66.93%76.72%86.15%7.42%17.81%14.34%12.18%-4.77%-22.88%-25.55%
Assets Growth (3y) 15.38%14.89%14.58%
Assets (QoQ) -6.56%-7.25%-8.16%88.68%3.87%-1.81%-3.27%8.88%13.92%-4.70%-5.10%-7.57%-7.75%-8.00%
Capital Expenditures Growth (1y) 180.81%96.39%78.77%37.85%-49.76%-31.27%-55.87%-34.94%36.52%-73.71%-126.76%
Capital Expenditures Growth (3y) 24.42%-29.20%-30.28%
Capital Expenditures (QoQ) 30.47%4.52%-12.59%135.59%-8.75%-4.86%-32.60%-14.14%24.82%-38.91%-0.63%80.16%-75.96%-162.18%
Cash & Equivalents Growth (1y) 168.96%-12.24%-2.68%49.70%-69.94%132.31%50.44%49.72%-0.88%-60.87%19.52%
Cash & Equivalents Growth (3y) -7.11%-7.26%20.50%
Cash & Equivalents (QoQ) 7.36%-41.33%-15.30%404.13%-64.97%-34.94%30.30%1.23%170.70%-57.87%29.68%-32.97%6.85%28.70%
Cash from Investing Activities Growth (1y) 77.72%-567.52%63.12%1.34%164.65%78.47%-2,119.08%180.23%-81.71%238.61%159.22%
Cash from Investing Activities Growth (3y) 26.54%11.74%89.88%
Cash from Investing Activities (QoQ) 113.34%-141.83%285.44%-315.22%-180.03%96.70%609.58%37.31%-193.25%-240.10%164.35%-91.04%606.61%45.31%
Cash from Operations Growth (1y) 1,068.98%-94.85%10.88%85.30%-112.55%213.51%0.92%-687.57%-50.90%-174.03%-16.68%
Cash from Operations Growth (3y) -22.42%-17.87%-1.00%
Cash from Operations (QoQ) 14.21%-52.60%0.65%844.94%-117.25%30.20%83.62%-535.91%256.09%-160.92%-30.24%-21.84%23.42%3.99%
EBITDA Margin Growth (1y) 5,982.0020,272.00-14730.002,147.00-12105.00-227033.00-265570.00
EBITDA Margin (QoQ) -12388.0022,694.00-10340.006,015.001,903.00-12308.006,536.00-8237.00-213025.00-50845.00
EBIT Growth (1y) 73.91%30.88%154.03%119.18%465.28%427.77%-254.57%-219.61%-203.21%-187.69%-117.25%
EBIT Growth (3y) 0.55%-25.71%-21.96%
EBIT Margin Growth (1y) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00
EBIT Margin (QoQ) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00
EBIT (QoQ) -6.46%-9.98%1.38%77.40%-181.99%185.97%-64.99%330.44%153.03%-140.54%72.91%-271.40%-115.00%-0.43%
EBT Growth (1y) 85.59%47.88%171.86%137.52%910.98%578.35%-187.98%-107.83%-168.50%-174.28%-173.60%
EBT Growth (3y) 7.15%-22.80%-20.04%
EBT Margin Growth (1y) 5,520.0012,752.00-12251.00-2402.00-12723.00-226231.00-261272.00
EBT Margin (QoQ) -5413.0010,779.00-1922.002,076.001,819.00-14223.007,927.00-8245.00-211689.00-49265.00
EBT (QoQ) -6.96%-8.45%2.02%87.32%-286.84%249.52%-48.84%174.07%128.17%-127.50%95.44%-2,296.27%-147.42%-1.29%
Enterprise Value Growth (1y) 469.87%206.91%69.95%44.59%142.11%-30.04%30.58%25.20%-33.28%-38.28%-79.42%
Enterprise Value Growth (3y) 109.58%9.84%-22.99%
Enterprise Value (QoQ) 366.26%102.35%8.14%-44.15%151.12%12.05%-8.00%-6.48%-27.44%109.16%-11.79%-50.16%-32.89%-30.26%
EPS (Basic) Growth (1y) 69.57%-5.41%233.75%62.82%433.33%306.41%-132.71%89.66%-160.00%-164.60%-202.86%
EPS (Basic) Growth (3y) 15.25%-12.01%-9.83%
EPS (Basic) (QoQ) -7.25%-8.11%2.50%73.08%-271.43%237.18%-127.10%341.38%130.00%-121.74%91.43%-1,300.00%-147.62%-1.92%
EPS (Weighted Average and Diluted) Growth (1y) 69.57%-5.41%227.50%64.10%423.81%298.72%-134.31%85.71%-161.76%-167.10%-202.86%
EPS (Weighted Average and Diluted) Growth (3y) 15.25%-12.01%-9.83%
EPS (Weighted Average and Diluted) (QoQ) -7.25%-8.11%2.50%73.08%-271.43%230.77%-127.45%342.86%127.94%-122.58%88.57%-950.00%-147.62%-1.92%
FCF Margin Growth (1y) -84320.0024,246.00-6795.00-7429.00-14829.00-156732.00-161636.00
FCF Margin (QoQ) -100012.0014,219.004,739.00-3266.008,554.00-16822.004,105.00-10667.00-133349.00-21726.00
Free Cash Flow Growth (1y) 1,034.59%-94.92%8.31%82.19%-113.07%205.94%3.99%-546.22%-50.44%-176.74%-13.00%
Free Cash Flow Growth (3y) -22.47%-16.58%0.18%
Free Cash Flow (QoQ) 12.98%-50.62%0.99%820.16%-118.15%29.15%80.77%-428.30%247.16%-164.21%-29.45%-22.99%24.94%5.45%
Net Cash Flow Growth (1y) 190.13%-2,475.22%25.81%292.79%-99.54%178.98%-284.78%47.34%-4,101.68%-96.02%119.41%
Net Cash Flow Growth (3y) 45.17%-9.31%36.69%
Net Cash Flow (QoQ) 103.08%-703.12%78.29%2,338.05%-181.05%81.16%156.42%-94.69%13,906.83%-191.77%121.61%-244.09%113.92%347.88%
Net Income Growth (1y) 68.98%-11.86%241.08%61.43%449.49%312.08%-139.46%111.63%-173.84%-178.42%-215.75%
Net Income Growth (3y) 7.15%-22.99%-20.68%
Net Income (QoQ) -6.96%-8.45%2.02%72.70%-285.66%236.77%-126.79%347.33%134.04%-125.45%107.90%-1,670.05%-148.57%-2.45%
Net Income towards Common Stockholders Growth (1y) 68.98%-11.86%241.08%61.43%449.49%312.08%-139.46%111.63%-173.84%-178.42%-215.75%
Net Income towards Common Stockholders Growth (3y) 7.15%-22.99%-20.68%
Net Income towards Common Stockholders (QoQ) -6.96%-8.45%2.02%72.70%-285.66%236.77%-126.79%347.33%134.04%-125.45%107.90%-1,670.05%-148.57%-2.45%
Net Margin Growth (1y) 6,636.0020,077.00-15258.002,566.00-12413.00-226961.00-266580.00
Net Margin (QoQ) -11608.0022,378.00-10379.006,244.001,833.00-12957.007,445.00-8735.00-212715.00-52576.00
Operating Income Growth (1y) 73.91%30.88%154.03%119.18%465.28%427.77%-254.57%-219.61%-203.21%-187.69%-117.25%
Operating Income Growth (3y) 0.55%-25.71%-21.96%
Operating Income (QoQ) -6.46%-9.98%1.38%77.40%-181.99%185.97%-64.99%330.44%153.03%-140.54%72.91%-271.40%-115.00%-0.43%
Operating Margin Growth (1y) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00
Operating Margin (QoQ) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00
Profit After Tax Growth (1y) 69.24%-11.86%241.07%61.25%452.05%312.25%-139.57%111.85%-173.84%-178.32%-214.52%
Profit After Tax Growth (3y) 7.19%-22.97%-20.64%
Profit After Tax (QoQ) -6.82%-8.45%2.02%72.90%-288.49%236.77%-126.91%346.19%134.21%-125.50%108.06%-1,633.95%-148.45%-2.39%
Property, Plant & Equipment (Net) Growth (1y) 30.53%41.53%48.33%45.70%17.12%2.96%-2.32%-2.35%-2.98%-13.55%-22.07%
Property, Plant & Equipment (Net) Growth (3y) 14.04%8.00%4.13%
Property, Plant & Equipment (Net) (QoQ) 8.17%-4.38%3.18%22.30%17.29%0.22%1.35%-1.69%3.11%-4.92%1.32%-2.32%-8.12%-14.29%
Return on Assets Growth (1y) 35.0027.0036.0014.0014.000.00-35.00-34.00
Return on Assets (QoQ) 14.005.0013.003.006.0014.00-9.002.00-7.00-21.00-8.00
Return on Capital Employed Growth (1y) 39.0045.0041.0022.0010.00-7.00-42.00-41.00
Return on Capital Employed (QoQ) 3.0017.0010.009.009.0013.00-9.00-2.00-9.00-22.00-8.00
Return on Equity Growth (1y) 40.0045.0068.0023.0018.00-3.00-48.00-42.00
Return on Equity (QoQ) 6.00-2.0028.007.0012.0021.00-17.003.00-10.00-24.00-10.00
Return on Invested Capital Growth (1y) -49.00-43.00
Return on Invested Capital (QoQ) 20.00-16.001.00-9.00
Return on Sales Growth (1y) 36.000.00-136.00-194.00
Return on Sales (QoQ) 20.0029.00-18.006.00-17.00-107.00-76.00
Revenue Growth (1y) 134.05%421.16%-55.25%-10.63%-65.23%-97.94%-91.75%
Revenue (QoQ) -28.07%140.70%-4.31%41.27%60.17%-79.33%91.10%-45.03%-90.51%-17.23%
Share-based Compensation Growth (1y) 53.57%24.16%25.45%33.28%35.50%48.19%43.11%22.36%36.27%9.22%5.27%
Share-based Compensation Growth (3y) 41.54%26.19%23.64%
Share-based Compensation (QoQ) 40.02%7.76%6.46%-4.41%13.21%8.88%13.10%-2.81%23.81%5.15%-3.29%8.23%-0.77%1.35%
Shareholder's Equity Growth (1y) -17.22%-19.19%5.76%14.02%17.31%107.79%71.26%76.88%54.90%-11.73%-19.35%
Shareholder's Equity Growth (3y) 14.58%14.02%13.47%
Shareholder's Equity (QoQ) -7.70%-8.91%-8.86%8.03%-9.89%19.21%-1.74%11.14%59.61%-1.74%1.47%-2.66%-9.05%-10.22%
Tax Rate (QoQ) -238.00711.00